The table below shows AYTU BIOPHARMA, INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$1.94M
-$1.39M
-$5.13M
-$28.82M
-$25.96M
-$28.37M
Capital expenditure
$228.00K
$329.00K
-
-
-
$0.00
Investing cash flow
-$2.56M
-$329.00K
-$117.00K
-$3.25M
-$2.78M
-$5.66M
Dividends paid
-
-
-
-
AYTU operating cash flow (10-K history)
AYTU BIOPHARMA, INC reported operating cash flow of -$1.94M for fiscal year 2025. That is down 39.6% from -$1.39M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$37.70K (FY 2013) to -$1.94M. Figures come from the company's audited annual reports as filed with the SEC.